DexCom Stock Forecast
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 1:01 PM ET
DXCM analyst consensus
Consensus (29 analysts)
strong_buy
Avg. price target
$96.23+14.52%
- Strong buy 4
- Buy 22
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 29 Wall Street analysts covering DexCom (2026-10-09), 26 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $96.23, with a high estimate of $115.00 and a low estimate of $79.00. The average target implies upside of 14.5% from the current price of $84.03.
The spread between the highest and lowest targets is 45.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for DXCM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 4 | 14% |
| Buy | 22 | 76% |
| Hold | 3 | 10% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $79.00 | -5.99% |
| Average target | $96.23 | +14.52% |
| High target | $115.00 | +36.86% |